Biotronik initiates global pivotal study evaluating LivIQ leadless pacemaker system Posted on March 27th, 2026 by LEADconnection Post navigation Previous: Pacing-induced cardiomyopathy: A narrative review.Next: Precision patient selection for ablate-and-pace: a multi-center study comparing leadless pacemaker vs. standard pacemaker in patients with indication to ablate-and-pace for atrial fibrillation (LEAD-AP).
Two Conduction-System Pacing RCTs Give Conflicting Results Posted on March 20th, 2026 by LEADconnection Post navigation Previous: Risk stratification in transvenous lead extraction: Current models and clinical applications.Next: Medtronic OmniaSecure™ defibrillation lead is the first lead of its kind to receive FDA approval for conduction system pacing
TTVR Remains Safe, Effective in Presence of CIED Leads Posted on October 25th, 2025 by LEADconnection Post navigation Previous: Outcomes of device extraction in patients with chronic kidney disease on renal replacement therapy and cardiac implantable electronic device infections.Next: Establishing a Cardiac Implantable Electronic Device Lead Extraction Program in a Resource-Limited Setting.